252 related articles for article (PubMed ID: 23714463)
1. Connecting molecular pathways to hereditary cancer risk syndromes.
Testa JR; Malkin D; Schiffman JD
Am Soc Clin Oncol Educ Book; 2013; ():81-90. PubMed ID: 23714463
[TBL] [Abstract][Full Text] [Related]
2. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM
BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282
[TBL] [Abstract][Full Text] [Related]
3. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
[TBL] [Abstract][Full Text] [Related]
4. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
Marušić Z; Buljan M; Busam KJ
J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
[TBL] [Abstract][Full Text] [Related]
5. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
[TBL] [Abstract][Full Text] [Related]
7. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
Wang G; Rao P
Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
[TBL] [Abstract][Full Text] [Related]
8. Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.
Kadariya Y; Cheung M; Xu J; Pei J; Sementino E; Menges CW; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR
Cancer Res; 2016 May; 76(9):2836-44. PubMed ID: 26896281
[TBL] [Abstract][Full Text] [Related]
9. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
Pilarski R; Cebulla CM; Massengill JB; Rai K; Rich T; Strong L; McGillivray B; Asrat MJ; Davidorf FH; Abdel-Rahman MH
Genes Chromosomes Cancer; 2014 Feb; 53(2):177-82. PubMed ID: 24243779
[TBL] [Abstract][Full Text] [Related]
10. BAPoma presenting as an incidental scalp papule: case report, literature review, and screening recommendations for BAP1 tumor predisposition syndrome.
Zaayman M; Nguyen P; Silfvast-Kaiser A; Frieder J; West C; Tumminello K; Paek SY
J Dermatolog Treat; 2022 Jun; 33(4):1855-1860. PubMed ID: 34106034
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
Rai K; Pilarski R; Cebulla CM; Abdel-Rahman MH
Clin Genet; 2016 Mar; 89(3):285-94. PubMed ID: 26096145
[TBL] [Abstract][Full Text] [Related]
12. Genetics of hereditary head and neck paragangliomas.
Boedeker CC; Hensen EF; Neumann HP; Maier W; van Nederveen FH; Suárez C; Kunst HP; Rodrigo JP; Takes RP; Pellitteri PK; Rinaldo A; Ferlito A
Head Neck; 2014 Jun; 36(6):907-16. PubMed ID: 23913591
[TBL] [Abstract][Full Text] [Related]
13. SDHA is a tumor suppressor gene causing paraganglioma.
Burnichon N; Brière JJ; Libé R; Vescovo L; Rivière J; Tissier F; Jouanno E; Jeunemaitre X; Bénit P; Tzagoloff A; Rustin P; Bertherat J; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2010 Aug; 19(15):3011-20. PubMed ID: 20484225
[TBL] [Abstract][Full Text] [Related]
14. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications.
Stratakis CA; Carney JA
J Intern Med; 2009 Jul; 266(1):43-52. PubMed ID: 19522824
[TBL] [Abstract][Full Text] [Related]
15. Clinical Implications of Real-time Integrative Sequencing in Management of Patients With Suspected Germline BAP1 Mutations.
Sengupta S; Weyand AC; Upadhyaya SA; Wu YM; Robinson DR; Mody RJ
J Pediatr Hematol Oncol; 2019 May; 41(4):e263-e265. PubMed ID: 29554022
[TBL] [Abstract][Full Text] [Related]
16. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Investigation of Lesions Associated with Succinate Dehydrogenase Defects.
Taïeb D; Timmers H; Pacak K
Horm Metab Res; 2019 Jul; 51(7):414-418. PubMed ID: 29618137
[TBL] [Abstract][Full Text] [Related]
18. SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors.
Gaal J; Stratakis CA; Carney JA; Ball ER; Korpershoek E; Lodish MB; Levy I; Xekouki P; van Nederveen FH; den Bakker MA; O'Sullivan M; Dinjens WN; de Krijger RR
Mod Pathol; 2011 Jan; 24(1):147-51. PubMed ID: 20890271
[TBL] [Abstract][Full Text] [Related]
19. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.
Pasini B; Stratakis CA
J Intern Med; 2009 Jul; 266(1):19-42. PubMed ID: 19522823
[TBL] [Abstract][Full Text] [Related]
20. Hereditary paragangliomas.
Raygada M; Pasini B; Stratakis CA
Adv Otorhinolaryngol; 2011; 70():99-106. PubMed ID: 21358191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
